Saudi Conference on Gynecology and Fertility spotlights AI in reproductive medicine

The inaugural Saudi Conference on Gynecology and Fertility (GFS) concluded in Jeddah this week, placing artificial intelligence and digital innovation at the centre of discussions on the future of fertility care. The three-day event, held from January 29 to 31 under the patronage of His Highness Prince Saud bin Abdullah bin Jalawi Al Saud, Governor of Jeddah, brought together more than 40 local and international experts to explore how advanced technologies are transforming reproductive medicine.

Organised by Dr. Ayman Oraif, Consultant and Director of the IVF Center and Reproductive Surgery at King’s College Hospital London – Jeddah, the conference featured workshops on fertility treatments, minimally invasive gynecologic surgery, and the use of AI to improve embryo selection, laboratory standards, and clinical outcomes.

Experts described this digital integration, referred to as “Embryology 4.0,” as a transformative step in fertility care, combining medical expertise with machine learning and data-driven assessment to enhance precision, efficiency, and patient success rates.

Dr. Oraif also highlighted emerging research on stem cell therapies for infertility and premature ovarian insufficiency, noting preliminary studies showing improvements in ovarian function, hormone regulation, and pregnancy rates. Complementary treatments, such as platelet-rich plasma therapy, were discussed for their potential to enhance oocyte quality.

The conference marked a milestone in specialised medical education in Saudi Arabia and reinforced the Kingdom’s growing role as a hub for medical innovation. Organisers said it is expected to foster collaboration with international institutions and further explore the potential of artificial intelligence and regenerative medicine in women’s health and fertility care.